Integration of Takara Bio USA’s Trekker® reagent kit with Illumina’s Single Cell 3′ RNA Prep assay delivers high-density, high-sensitivity spatial data with true single-cell resolution SAN JOSE, Calif ...

Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

Figuring out who to screen could change the game. This discovery is getting us closer.

Halozyme Therapeutics, Inc. ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, is ...

Hoot Health today announced its entry into the pharmaceutical market with an AI-powered, physician-led patient education engine designed to address one of the industry's most costly challenges: failed ...